GlobeNewsWire
20 Nov 2025, 21:35 UTC · 49w ago
Equillium to Participate in Upcoming Investor Conferences
Verdict
Headline takes no side. We score EQ +0.10 across one claim — slightly bullish.
- Expected · EQ
+0.10slightly bullish
−1 bearish0bullish +1More positive than 44% of ticker scores this week
- Actual
Scored by the NIS engine · methodology.

- pharmaceuticals
- EQ
- autoimmune disorders
- biotechnology
- clinical stage
- inflammatory disorders
- investor conference
Search tags




